Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-anchored junction protein (MAJIN) is a meiosis-specific telomere-associated protein anchored to the inner nuclear membrane. It is essential for the proper attachment of telomeric DNA to the nuclear envelope during meiotic prophase I, facilitating homologous chromosome pairing and synapsis. Acting as an anchoring subunit in the MAJIN-TERB1-TERB2 complex, it stabilizes telomere localization at the nuclear envelope and is crucial for fertility, as knockout studies result in defective meiosis and infertility. MAJIN is predicted to exhibit DNA binding activity, and participates upstream in processes like double-strand break repair, oogenesis, and spermatogenesis. Its dysfunction is associated with rare developmental disorders but not with cancer or common therapeutic areas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-anchored junction protein (MAJIN).